Labcorp expanded its partnership with PathAI to offer its FDA-cleared digital pathology platform at the life science giant’s U.S. network of anatomical pathology labs and participating hospitals.
Pixel by LabCorp ℠ Offers Self-Collected Testing Anytime, Anywhere to Empower Healthcare Consumers BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, today ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp® (NYSE: LH), a leading global life sciences company, today announced a new collaboration with HealthVerity, Inc., the ...
Labcorp’s pathologists will use the software to review, interpret and manage digital images of slides for primary diagnosis.
Clinical Development Business to be a Leading, Pure-Play Contract Research Organization with a Comprehensive Set of Clinical Trial Management, Market Access and Technology Capabilities Labcorp Remains ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that the new company to be formed by the planned spin-off of its Clinical Development ...
“Adding Toxikon underscores our commitment to nonclinical development and advances our capabilities for both drug development and medical device testing,” said Dr. Paul Kirchgraber, CEO of Labcorp ...
LabCorp Enters Definitive Agreement to Acquire Monogram Biosciences, Inc. Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) and Monogram Biosciences, Inc. (NASDAQ: MGRM) today ...
Strategic Partnership Includes Development of New Facility, Enhanced Service for Global Clinical Trials Through the planned laboratory expansion, Labcorp will advance biomarker and esoteric testing ...
BURLINGTON, N.C., Sept. 25, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third ...
BURLINGTON, N.C., Jan. 15, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth ...
Clients: Physicians, patients, biopharmaceutical companies, government agencies, managed care organizations, hospitals and clinical labs. Specialty testing group: Includes endocrine testing; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results